PODD
Insulet
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: PODD
- PE Ratio
As of Aug 21, 2026, the Insulet stock's PE ratio is 27.69. This takes into account the latest EPS of $5.35 and stock price of $148.16. The PE ratio marks a decrease of 55% from its last 4 quarters average of 61.6.
PODD PE ratio history
The PE ratio of Insulet has averaged 1761.66 over the last eight years. The current P/E ratio of 27.69 is 98% lower than the historical average. Looking back at the last eight years, PODD's PE ratio peaked in the Mar 2023 quarter at 31,896, when the price was $318.96 and the EPS was $0.01. The lowest point was in the Jun 2026 quarter, when it reached 28.46 with a price of $152.25 and an EPS of $5.35.
Insulet PE ratio by year
Maximum annual increase: 295.16% in 2022
Maximum annual decrease: -98.26% in 2023
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 80.98 | 85.18% | $284.24 | $3.51 |
| 2024 | 43.73 | -40.34% | $261.07 | $5.97 |
| 2023 | 73.3 | -98.26% | $216.98 | $2.96 |
| 2022 | 4,205.57 | 295.16% | $294.39 | $0.07 |
| 2021 | 1,064.28 | -54.2% | $266.07 | $0.25 |
| 2020 | 2,323.91 | 157.91% | $255.63 | $0.11 |
| 2019 | 901.05 | -31.84% | $171.2 | $0.19 |
| 2018 | 1,322 | N/A | $79.32 | $0.06 |
| 2017 | N/A | N/A | $69 | -$0.46 |
| 2016 | N/A | N/A | $37.68 | -$0.51 |
| 2015 | N/A | N/A | $37.81 | -$1.29 |
| 2014 | N/A | N/A | $46.06 | -$0.92 |
| 2013 | N/A | N/A | $37.1 | -$0.83 |
| 2012 | N/A | N/A | $21.22 | -$1.08 |
| 2011 | N/A | N/A | $18.83 | -$0.98 |
Insulet PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2026 | 28.46 | -41.68% | $152.25 | $5.35 |
| Mar 2026 | 48.8 | -39.74% | $209.84 | $4.3 |
| Dec 2025 | 80.98 | -8.2% | $284.24 | $3.51 |
| Sep 2025 | 88.21 | -5.38% | $308.73 | $3.5 |
| Jun 2025 | 93.23 | 103.78% | $314.18 | $3.37 |
| Mar 2025 | 45.75 | 4.62% | $262.61 | $5.74 |
| Dec 2024 | 43.73 | 13.11% | $261.07 | $5.97 |
| Sep 2024 | 38.66 | 8.23% | $232.75 | $6.02 |
| Jun 2024 | 35.72 | -30.18% | $201.8 | $5.65 |
| Mar 2024 | 51.16 | -30.2% | $171.4 | $3.35 |
| Dec 2023 | 73.3 | -20.95% | $216.98 | $2.96 |
| Sep 2023 | 92.73 | -71.06% | $159.49 | $1.72 |
| Jun 2023 | 320.38 | -99% | $288.34 | $0.9 |
| Mar 2023 | 31,896 | 658.42% | $318.96 | $0.01 |
| Dec 2022 | 4,205.57 | 358.32% | $294.39 | $0.07 |
PODD Price vs fair value
PODD average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
PODD's current PE ratio is lower than its 3, 5 and 10-year averages.
PE comparison
With a price to earnings (P/E) of 27.69, PODD ranks higher than the Healthcare sector average but lower than the industry and its peers average. In comparison with the Healthcare sector average of 24.4, Insulet's price to earnings (P/E) is 13% higher.
PODD PE vs peers
Frequently asked questions
What is Insulet's PE ratio?
PODD stock has a price to earnings ratio of 27.69 as of Aug 21, 2026.
What is the 3-year average PE ratio for Insulet (PODD)?
The average PE ratio for PODD stock over the past 3 years is 60.06.
What is the 5-year average PE ratio for Insulet (PODD)?
The average PE ratio for PODD stock over the past 5 years is 2103.59.
What is the highest PE ratio for PODD?
Over the last eight years, the quarterly PE ratio reached its highest level at 31,896 in the Mar 2023 quarter.
How does the current PE ratio for PODD compare to its historical average?
PODD's price to earnings ratio is currently 98% below its 8-year historical average.
How is PODD's PE ratio calculated (Insulet PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Aug 21, 2026), Insulet's share price is $148.16. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2026 is $5.35. Therefore, Insulet's PE ratio for today is 27.69. PE RATIO(27.69) = STOCK PRICE($148.16) / TTM EPS($5.35)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.